中国比较医学杂志2024，Vol.34Issue(4)：109-113,5.DOI:10.3969/j.issn.1671-7856.2024.04.013
医药学实验室潜在的生物安全风险与防范措施
Risks of biosafety and prevention strategies in medical and pharmaceutical research laboratories
陈沫 1陶佳颐 1王宏旭 1张庆建1
作者信息
- 1. 中国医学科学院药物研究所,条件设备处,北京 100050
- 折叠
摘要
Abstract
Medical and pharmaceutical research laboratories encompass a wide range of study areas.They utilize diverse materials ranging from animals and microorganisms to nanoparticles and other substances.However,as laboratory waste increases,more biosafety risks are created.In this context,we outlined the safety risks associated with gene amplification,gene recombination,research involving pathogenic microorganisms,nanotechnology,animal experiments,genetically modified animals,and experimental waste.Additionally,we here in propose preventive measures to mitigate laboratory biosafety risks.These measures primarily involve the development of strict legal frameworks,improvement of hardware infrastructure,strengthening of safety awareness,and enhancement of education and training programs.关键词
医药学研究实验室/生物安全/安全管理Key words
medical and pharmaceutical research laboratory/biosafety/safety management分类
医药卫生引用本文复制引用
陈沫,陶佳颐,王宏旭,张庆建..医药学实验室潜在的生物安全风险与防范措施[J].中国比较医学杂志,2024,34(4):109-113,5.
